On January 15, 2025, the US Drug Enforcement Administration (DEA) released a proposed rule entitled Special Registrations for ...
Rule will make permanent the temporary waivers easing access to buprenorphine via telehealth that began during the COVID-19 ...
The monthslong battle over the future of the weight-loss drug industry is headed for a climax this week, when the Food and Drug Administration ... sprawling industry of telehealth companies ...
A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, ...
The United States Food and Drug Administration says the shortage ... With demand for these drugs skyrocketing, telehealth and compounding pharmacies like Hims and Ro began to offer off-brand ...
The Food and Drug Administration said that a nationwide ... With demand for GLP-1 drugs booming, compounding pharmacies and telehealth companies like Hims and Ro have jumped into the market ...